These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 20275117)

  • 1. The treatment by 2,3-dimercaptopropanol (BAL) of the systemic toxic effects of skin contamination with lewisite and phenyldichlorarsine.
    HARRISON HE; DURLACHER SH
    J Pharmacol Exp Ther; 1946 Aug; 87(4 Suppl):81-4. PubMed ID: 20275117
    [No Abstract]   [Full Text] [Related]  

  • 2. Poisoning from inhalation of the vapors of lewisite and phenyldichlorarsine; its pathology in the dog and treatment with 2,3-dimercaptopropanol (BAL).
    HARRISON HE; ORDWAY NK
    J Pharmacol Exp Ther; 1946 Aug; 87(4 Suppl):76-80. PubMed ID: 20275116
    [No Abstract]   [Full Text] [Related]  

  • 3. British anti-lewisite; arsenic and thiol excretion in animals after treatment of lewisite burns.
    STOCKEN LA; THOMPSON RH
    Biochem J; 1946 Jul; 40(4):548-54. PubMed ID: 20273640
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical uses of 2,2-dimercaptopropanol (BAL); the systemic treatment of experimental arsenic poisoning (mapharsen, lewisite, phenyl arsenoxide) with BAL.
    EAGLE H; MAGNUSON HJ; FLEISCHMAN R
    J Clin Invest; 1946 Jul; 25(4):451-66. PubMed ID: 21001620
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical uses of 2,3-dimercaptopropanol (BAL); the treatment of lewisite burns of the eye with BAL.
    HUGHES WF
    J Clin Invest; 1946 Jul; 25(4):541-8. PubMed ID: 21001628
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical uses of 2,3-dimercaptopropanol (BAL); the effect of BAL on the excretion of arsenic in arsenical intoxication.
    LUETSCHER JA; EAGLE H; LONG-COPE WT
    J Clin Invest; 1946 Jul; 25(4):534-40. PubMed ID: 21001627
    [No Abstract]   [Full Text] [Related]  

  • 7. The treatment of acute gold and arsenic poisoning; use of BAL (2,3-dimercaptopropanol, British anti-lewisite).
    COHEN A; GOLDMAN J; DUBBS AW
    J Am Med Assoc; 1947 Mar; 133(11):749-52. PubMed ID: 20283984
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical uses of 2,3-dimercaptopropanol (BAL); the treatment of arsenical dermatitis with preparations of BAL.
    LONGCOPE WT; LUETSCHER JA
    J Clin Invest; 1946 Jul; 25(4):528-33. PubMed ID: 21001626
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of 2,3-dimercaptopropanol (BAL) on the whole blood and plasma concentration of arsenic after mapharsen in cats.
    RIKER WF; ROSENFELD G
    J Pharmacol Exp Ther; 1946 Aug; 87(4 Suppl):72-5. PubMed ID: 20275115
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of lewisite burns of the eye with dimercaprol (BAL).
    HUGHES WF
    Arch Ophthal; 1947 Jan; 37(1):25-41. PubMed ID: 20285740
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical uses of 2,3-dimercaptopropanol (BAL); the treatment of complications of arseno-therapy with BAL (British anti-lewisite).
    CARLETON AB; PETERS RA
    J Clin Invest; 1946 Jul; 25(4):497-527. PubMed ID: 21001625
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathologic study of ocular lesions due to lewisite (B-chlorovinyldichloroarsine) changes with and without BAL (2,3-dimercaptopropanol) therapy.
    ADLER FH; FRY WE; LEOPOLD IH
    Arch Ophthal; 1947 Jul; 38(1):89-108. PubMed ID: 20258239
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the efficacy of dimercapto chelating agents for the treatment of systemic organic arsenic poisoning in rabbits.
    Inns RH; Rice P; Bright JE; Marrs TC
    Hum Exp Toxicol; 1990 Jul; 9(4):215-20. PubMed ID: 2167707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic distribution in rabbits after Lewisite administration and treatment with British anti-Lewisite (BAL).
    Snider TH; Wientjes MG; Joiner RL; Fisher GL
    Fundam Appl Toxicol; 1990 Feb; 14(2):262-72. PubMed ID: 2318351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. British anti-lewisite; antidotal effects against therapeutic arsenicals.
    STOCKEN LA; THOMPSON RH; WHITTAKER VP
    Biochem J; 1947; 41(1):47-52. PubMed ID: 20287850
    [No Abstract]   [Full Text] [Related]  

  • 16. The systemic treatment of arsenic poisoning with BAL (2,3-dimercaptopropanol).
    EAGLE H
    J Vener Dis Inf; 1946 May; 27():114-21. PubMed ID: 21028660
    [No Abstract]   [Full Text] [Related]  

  • 17. Topical efficacy of dimercapto-chelating agents against lewisite-induced skin lesions in SKH-1 hairless mice.
    Mouret S; Wartelle J; Emorine S; Bertoni M; Nguon N; Cléry-Barraud C; Dorandeu F; Boudry I
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):291-8. PubMed ID: 23806213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tests of 2,3-dimercaptopropanol and related dithiols for decontamination of lewisite on human skin.
    THOMSON JF; SAVIT J; GOLDWASSER E
    J Pharmacol Exp Ther; 1947 Jan; 89(1):1-13. PubMed ID: 20281334
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of various dithiol compounds in acute As2O3 poisoning in mice.
    Kreppel H; Reichl FX; Szinicz L; Fichtl B; Forth W
    Arch Toxicol; 1990; 64(5):387-92. PubMed ID: 2169719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of lewisite and other arsenical vesicant lesions of the eyes of rabbits with British anti-lewisite (BAL).
    MANN I; PIRIE A; PULLINGER BD
    Am J Ophthalmol; 1947 Apr; 30(4):421-35. PubMed ID: 20256316
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.